{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T08:25:04Z","timestamp":1765268704550},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T00:00:00Z","timestamp":1596672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T00:00:00Z","timestamp":1596672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s10147-020-01757-z","type":"journal-article","created":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T02:02:26Z","timestamp":1596679346000},"page":"2066-2074","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["FLOX (5-fluorouracil\u2009+\u2009leucovorin\u2009+\u2009oxaliplatin) chemotherapy for colorectal cancer leads to long-term orofacial neurotoxicity: a STROBE-guided longitudinal prospective study"],"prefix":"10.1007","volume":"25","author":[{"given":"Priscilla","family":"de Albuquerque Ribeiro Gondinho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo Goberl\u00e2nio","family":"de Barros Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rio Roberto Pontes","family":"Lisboa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno Almeida","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Du\u00edlio Reis","family":"da Rocha Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus Andret Cavalcante","family":"Gifoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos Venicio Alves","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto C\u00e9sar Pereira Lima","family":"Junior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana Lima","family":"Vale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,6]]},"reference":[{"issue":"15","key":"1757_CR1","doi-asserted-by":"publisher","first-page":"24593","DOI":"10.18632\/oncotarget.15598","volume":"8","author":"Z Li","year":"2017","unstructured":"Li Z, Yang L, Du C et al (2017) Characteristics and comparison of colorectal cancer incidence in Beijing with other regions in the world. Oncotarget 8(15):24593\u201324603. https:\/\/doi.org\/10.18632\/oncotarget.15598","journal-title":"Oncotarget"},{"issue":"1","key":"1757_CR2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/1878-0261.12018","volume":"11","author":"DV Tauriello","year":"2017","unstructured":"Tauriello DV, Calon A, Lonardo E et al (2017) Determinants of metastatic competency in colorectal cancer. Mol Oncol 11(1):97\u2013119. https:\/\/doi.org\/10.1002\/1878-0261.12018","journal-title":"Mol Oncol"},{"key":"1757_CR3","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1002\/ijc.30686","volume":"140","author":"MM Fidler","year":"2017","unstructured":"Fidler MM, Bray F, Vaccarella S et al (2017) Assessing global transitions in human development and CRC incidence. Int J Cancer 140:2709\u20132715. https:\/\/doi.org\/10.1002\/ijc.30686","journal-title":"Int J Cancer"},{"key":"1757_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.drup.2005.04.006","volume":"8","author":"V Brabec","year":"2005","unstructured":"Brabec V, Kasparkova J (2005) Modifications of DNA by platinum complexes Relation to resistance of tumors to platinum antitumor Drug. Drug Resist Update 8:131\u2013146. https:\/\/doi.org\/10.1016\/j.drup.2005.04.006","journal-title":"Drug Resist Update"},{"issue":"8","key":"1757_CR5","doi-asserted-by":"publisher","first-page":"e12445","DOI":"10.1371\/journal.pone.0012445","volume":"5","author":"D Kong","year":"2010","unstructured":"Kong D, Banerjee S, Ahmad A et al (2010) Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells. PLoS ONE 5(8):e12445. https:\/\/doi.org\/10.1371\/journal.pone.0012445","journal-title":"PLoS ONE"},{"issue":"23","key":"1757_CR6","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1056\/NEJMoa032709","volume":"350","author":"T Andr\u00e9","year":"2004","unstructured":"Andr\u00e9 T, Boni C, Mounedji-Boudiaf L et al (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350(23):2343\u20132351. https:\/\/doi.org\/10.1056\/NEJMoa032709","journal-title":"N Engl J Med"},{"issue":"16","key":"1757_CR7","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1200\/jco.2000.18.16.2938","volume":"18","author":"A Gramont","year":"2000","unstructured":"Gramont A, Figer A, Seymour M et al (2000) Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18(16):2938\u20132947. https:\/\/doi.org\/10.1200\/jco.2000.18.16.2938","journal-title":"J Clin Oncol"},{"issue":"1","key":"1757_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00003088-200038010-00001","volume":"38","author":"F L\u00e9vi","year":"2000","unstructured":"L\u00e9vi F, Metzger G, Massari C et al (2000) Oxaliplatin: pharmacokinetics and chronopharmacological aspects. Clin Pharmacokinet 38(1):1\u201321. https:\/\/doi.org\/10.2165\/00003088-200038010-00001","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"1757_CR9","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.ctrv.2008.01.003","volume":"34","author":"AA Argyriou","year":"2008","unstructured":"Argyriou AA, Polychronopoulos P et al (2008) A review on oxaliplatin-induced peripheral nerve damage. Cancer Treat Rev 34(4):368\u2013377. https:\/\/doi.org\/10.1016\/j.ctrv.2008.01.003","journal-title":"Cancer Treat Rev"},{"issue":"12","key":"1757_CR10","doi-asserted-by":"publisher","first-page":"e0170814","DOI":"10.1371\/journal.pone.0170814","volume":"2017","author":"PG Makker","year":"2017","unstructured":"Makker PG, Duffy SS, Lees JG et al (2017) Characterisation of immune and neuroinflammatory changes associated with chemotherapy-induced peripheral neuropathy. PLoS ONE 2017(12):e0170814. https:\/\/doi.org\/10.1371\/journal.pone.0170814","journal-title":"PLoS ONE"},{"key":"1757_CR11","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S0034-7094(11)70075-7","volume":"61","author":"DC Kraychete","year":"2011","unstructured":"Kraychete DC, Sakata RK (2011) Painful peripheral neuropathies. Rev Bras Anestesiol 61:641\u2013658. https:\/\/doi.org\/10.1016\/S0034-7094(11)70075-7","journal-title":"Rev Bras Anestesiol"},{"key":"1757_CR12","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.6004\/jnccn.2009.0078","volume":"5","author":"MD Stubblefield","year":"2009","unstructured":"Stubblefield MD, Burstein HJ, Burton AW et al (2009) NCCN task force report: management of neuropathy in cancer. J Natl Compr Canc Netw Suppl 5:S1\u2013S26. https:\/\/doi.org\/10.6004\/jnccn.2009.0078","journal-title":"J Natl Compr Canc Netw Suppl"},{"issue":"3","key":"1757_CR13","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/0030-4220(92)90063-v","volume":"74","author":"GM McCarthy","year":"1992","unstructured":"McCarthy GM, Skillings JR (1992) Jaw and other orofacial pain in patients receiving vincristine for the treatment of cancer. Oral Surg Oral Med Oral Pathol 74(3):299\u2013304. https:\/\/doi.org\/10.1016\/0030-4220(92)90063-v","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"1757_CR14","first-page":"59","volume":"1","author":"YP Wang","year":"2012","unstructured":"Wang YP, Wang YN, Xu Z et al (2012) Trigeminal neuralgia suspiciously caused by oxaliplatin for injection. Chin J Drug App Monit 1:59\u201360","journal-title":"Chin J Drug App Monit"},{"key":"1757_CR15","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/1471-2407-5-116","volume":"5","author":"GD Leonard","year":"2005","unstructured":"Leonard GD, Wright MA, Quinn MG et al (2005) Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancer. BMC Cancer 5:116. https:\/\/doi.org\/10.1186\/1471-2407-5-116","journal-title":"BMC Cancer"},{"issue":"4","key":"1757_CR16","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.nurt.2009.07.003","volume":"6","author":"N Authier","year":"2009","unstructured":"Authier N, Balayssac D, Marchand F et al (2009) Animal models of chemotherapy-evoked painful peripheral neuropathies. Neurotherapeutics 6(4):620\u2013629. https:\/\/doi.org\/10.1016\/j.nurt.2009.07.003","journal-title":"Neurotherapeutics"},{"issue":"2","key":"1757_CR17","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00520-013-2004-3","volume":"22","author":"S Vatandoust","year":"2014","unstructured":"Vatandoust S, Joshi R, Pittman KB et al (2014) A descriptive study of persistent oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer. Support Care Cancer 22(2):513\u2013518. https:\/\/doi.org\/10.1007\/s00520-013-2004-3","journal-title":"Support Care Cancer"},{"issue":"16","key":"1757_CR18","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1200\/JCO.2006.08.6652","volume":"25","author":"SR Land","year":"2007","unstructured":"Land SR, Kopec JA, Cecchini RS et al (2007) Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07. J Clin Oncol 25(16):2205\u20132211. https:\/\/doi.org\/10.1200\/JCO.2006.08.6652","journal-title":"J Clin Oncol"},{"issue":"4","key":"1757_CR19","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.11607\/ofph.1793","volume":"31","author":"CY Tan","year":"2017","unstructured":"Tan CY, Shahrizaila N, Goh KJ (2017) Clinical characteristics, pain, and quality of life experiences of trigeminal neuralgia in a multi-ethnic asian cohort. J Oral Facial Pain Headache 31(4):e15\u2013e20. https:\/\/doi.org\/10.11607\/ofph.1793","journal-title":"J Oral Facial Pain Headache"},{"issue":"3","key":"1757_CR20","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00405-018-05264-w","volume":"276","author":"S Lahtinen","year":"2019","unstructured":"Lahtinen S, Koivunen P, Ala-Kokko T et al (2019) Swallowing-related quality of life after free flap surgery due to cancer of the head and neck. Eur Arch Otorhinolaryngol 276(3):821\u2013826. https:\/\/doi.org\/10.1007\/s00405-018-05264-w","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"4","key":"1757_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/s0093-7754(03)00399-3","volume":"30","author":"A Grothey","year":"2003","unstructured":"Grothey A (2003) Oxaliplatin-safety profile: neurotoxicity. Semin Oncol 30(4):5\u201313. https:\/\/doi.org\/10.1016\/s0093-7754(03)00399-3","journal-title":"Semin Oncol"},{"issue":"3","key":"1757_CR22","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00520-014-2423-9","volume":"23","author":"S Padman","year":"2015","unstructured":"Padman S, Lee J, Kumar R et al (2015) Late effects of oxaliplatin-induced peripheral neuropathy (LEON)\u2013cross-sectional cohort study of patients with colorectal cancer surviving at least 2 years. Support Care Cancer 23(3):861\u2013869. https:\/\/doi.org\/10.1007\/s00520-014-2423-9","journal-title":"Support Care Cancer"},{"issue":"3","key":"1757_CR23","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.neulet.2010.09.028","volume":"486","author":"A Scuteri","year":"2010","unstructured":"Scuteri A, Galimberti A, Ravasi M et al (2010) NGF protects dorsal root ganglion neurons from oxaliplatin by modulating JNK\/Sapk and ERK1\/2. Neurosci Lett 486(3):141\u2013145. https:\/\/doi.org\/10.1016\/j.neulet.2010.09.028","journal-title":"Neurosci Lett"},{"issue":"12","key":"1757_CR24","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/nrneurol.2014.211","volume":"10","author":"M Sisignano","year":"2014","unstructured":"Sisignano M, Baron R, Scholich K et al (2014) Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain. Nat Rev Neurol 10(12):694\u2013707. https:\/\/doi.org\/10.1038\/nrneurol.2014.211","journal-title":"Nat Rev Neurol"},{"issue":"340","key":"1757_CR25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.taap.2018.01.001","volume":"2018","author":"AF Pereira","year":"2018","unstructured":"Pereira AF, de Oliveira FFB, de Freitas Alves BW et al (2018) Neurotoxic effect of oxaliplatin: comparison with its oxalate-free analogue cis-[PtII(1R,2R-DACH)(3-acetoxy-1,1-cyclobutanedicarboxylato)] (LLC-1402) in mice. Toxicol Appl Pharmacol 2018(340):77\u201384. https:\/\/doi.org\/10.1016\/j.taap.2018.01.001","journal-title":"Toxicol Appl Pharmacol"},{"key":"1757_CR26","doi-asserted-by":"publisher","first-page":"e0186250","DOI":"10.1371\/journal.pone.0186250","volume":"12","author":"P Marmiroli","year":"2017","unstructured":"Marmiroli P, Riva B, Pozzi E et al (2017) Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: phenotypic and genotypic insights. PLoS ONE 12:e0186250. https:\/\/doi.org\/10.1371\/journal.pone.0186250","journal-title":"PLoS ONE"},{"issue":"10","key":"1757_CR27","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/nrclinonc.2009.128","volume":"6","author":"D Schiff","year":"2009","unstructured":"Schiff D, Wen PY, van den Bent MJ (2009) Neurological adverse effects caused by cytotoxic and targeted therapies. Nat Rev Clin Oncol 6(10):596\u2013603. https:\/\/doi.org\/10.1038\/nrclinonc.2009.128","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"1757_CR28","doi-asserted-by":"publisher","first-page":"72","DOI":"10.4103\/1673-5374.198986","volume":"12","author":"MR Kelley","year":"2017","unstructured":"Kelley MR, Fehrenbacher JC (2017) Challenges and opportunities identifying therapeutic targets for chemotherapy-induced peripheral neuropathy resulting from oxidative DNA damage. Neural Regen Res 12(1):72\u201374. https:\/\/doi.org\/10.4103\/1673-5374.198986","journal-title":"Neural Regen Res"},{"issue":"4","key":"1757_CR29","first-page":"2301","volume":"22","author":"SS Shord","year":"2002","unstructured":"Shord SS, Bernard SA, Lindley C et al (2002) Oxaliplatin biotransformation and pharmacokinetics: a pilot study to determine the possible relationship to neurotoxicity. Anticancer Res 22(4):2301\u20132309","journal-title":"Anticancer Res"},{"issue":"4 Suppl 15","key":"1757_CR30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/s0093-7754(03)00400-7","volume":"30","author":"JH Doroshow","year":"2003","unstructured":"Doroshow JH, Synold TW, Gandara D et al (2003) Pharmacology of oxaliplatin in solid tumor patients with hepatic dysfunction: a preliminary report of the National Cancer Institute Organ Dysfunction Working Group. Semin Oncol 30(4 Suppl 15):14\u201319. https:\/\/doi.org\/10.1016\/s0093-7754(03)00400-7","journal-title":"Semin Oncol"},{"issue":"5","key":"1757_CR31","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s00280-013-2295-6","volume":"72","author":"B Kobrinsky","year":"2013","unstructured":"Kobrinsky B, Joseph SO, Muggia F et al (2013) A phase I and pharmacokinetic study of oxaliplatin and bortezomib: activity, but dose-limiting neurotoxicity. Cancer Chemother Pharmacol 72(5):1073\u20131078. https:\/\/doi.org\/10.1007\/s00280-013-2295-6","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"1757_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1590\/S2176-94512010000200013","volume":"15","author":"LPV Gon\u00e7alves","year":"2010","unstructured":"Gon\u00e7alves LPV, Toleto OA, Otero SAM (2010) The relationship between bruxism, occlusal factors and oral habits. Dent Press J Orthod 15(2):97\u2013104. https:\/\/doi.org\/10.1590\/S2176-94512010000200013","journal-title":"Dent Press J Orthod"},{"key":"1757_CR33","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/s1550-8579(05)80042-7","volume":"2","author":"Z Wiesenfeld-Hallin","year":"2005","unstructured":"Wiesenfeld-Hallin Z (2005) Sex differences in pain perception. Gend Med 2:137\u2013145. https:\/\/doi.org\/10.1016\/s1550-8579(05)80042-7","journal-title":"Gend Med"},{"issue":"6","key":"1757_CR34","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/S0034-7094(11)70091-5","volume":"61","author":"CC Palmeira","year":"2011","unstructured":"Palmeira CC, Ashmawi HA, Posso Ide P (2011) Sex and pain perception and analgesia. Rev Bras Anestesiol 61(6):814\u2013828. https:\/\/doi.org\/10.1016\/S0034-7094(11)70091-5","journal-title":"Rev Bras Anestesiol"},{"issue":"5","key":"1757_CR35","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/j.1600-0528.2009.00482.x","volume":"37","author":"TV Macfarlane","year":"2009","unstructured":"Macfarlane TV, Kenealy P, Kingdon HA et al (2009) Orofacial pain in young adults and associated childhood and adulthood factors: results of the population study, Wales, United Kingdom. Community Dent Oral Epidemiol 37(5):438\u2013450. https:\/\/doi.org\/10.1111\/j.1600-0528.2009.00482.x","journal-title":"Community Dent Oral Epidemiol"},{"issue":"2","key":"1757_CR36","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.cden.2004.10.011","volume":"49","author":"GT Clark","year":"2005","unstructured":"Clark GT, Minakuchi H, Lotaif AC (2005) Orofacial pain and sensory disorders in the elderly. Dent Clin North Am 49(2):343\u2013362. https:\/\/doi.org\/10.1016\/j.cden.2004.10.011","journal-title":"Dent Clin North Am"},{"issue":"3","key":"1757_CR37","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/s0304-3959(00)00408-5","volume":"90","author":"JL Riley 3rd","year":"2001","unstructured":"Riley JL 3rd, Gilbert GH (2001) Orofacial pain symptoms: an interaction between age and sex. Pain 90(3):245\u2013256. https:\/\/doi.org\/10.1016\/s0304-3959(00)00408-5","journal-title":"Pain"},{"issue":"9","key":"1757_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jnci\/djx028","volume":"109","author":"AD Falchook","year":"2017","unstructured":"Falchook AD, Dusetzina SB, Tian F et al (2017) Aggressive end-of-life care for metastatic cancer patients younger than Age 65 years. J Natl Cancer Inst 109(9):1\u20136. https:\/\/doi.org\/10.1093\/jnci\/djx028","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"1757_CR39","doi-asserted-by":"publisher","first-page":"4276","DOI":"10.1590\/s1413-81232011001100033","volume":"16","author":"JT Lacerda","year":"2011","unstructured":"Lacerda JT, Ribeiro JD, Ribeiro DM et al (2011) Prevalence of orofacial pain and its impact on the oral health-related quality of life of textile industries workers of Laguna, SC, Brazil. Ci\u00eanc sa\u00fade coletiva 16(10):4276\u20134282. https:\/\/doi.org\/10.1590\/s1413-81232011001100033","journal-title":"Ci\u00eanc sa\u00fade coletiva"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-020-01757-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-020-01757-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-020-01757-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T00:04:28Z","timestamp":1628208268000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-020-01757-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,6]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1757"],"URL":"https:\/\/doi.org\/10.1007\/s10147-020-01757-z","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,6]]},"assertion":[{"value":"27 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Gondinho PAR declares that he has no conflict of interest. Barros Silva PG declares that he has no conflict of interest. Lisboa MPR declares that he has no conflict of interest. Costa DRR declares that he has no conflict of interest. Rocha Filho DR declares that he has no conflict of interest. Gifoni MAC declares that he has no conflict of interest. Lima MVA declares that he has no conflict of interest. Lima Jr RCP declares that he has no conflict of interest. Alves MV declares that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}